Atoderm PP Baume

• Immediate and long-term hydration effect (+90.8% and +21,3% hydration rate after 2h and 24h) *(1)
• Regulates the balance of the skin's ecosystem, normalising its saprophytic flora and inhibiting the development of S. aureus (via its Ecodéfensine® patent) (2)
• Soothes irritation, itchiness (-68%)* and tightness (-100%) *(3,4)

Very good skin tolerance - Creamy texture - Instant absorption – Unfragranced (5)

Clinically tested on patients with atopic dermatitis with moderate intensity, with dry or moderately hydrated skin (1.3.4)
* p<0.05, Student’s test

(1)Evaluation of cutation hydration rate by corneometric of Atoderm PP Baume, double-blind study – 10 volunteers (aged 28 – 63 years old) with dry or moderately hydrated skin on their forearms with only one application. France
(2)Efficacy of Atoderm PP Baume on skin flora through determination and counts of Staphylococcus aureus strains and coagulase-negative Staphylococcus by swab sampling on the forearms, before and after 10 days of treatment. – 4 volunteers, healthy carriers of Staphylococcus aureus.
(3)Evaluation of Atoderm PP Baume in dry skin during Atopic Dermatitis – 40 patients (1- 14 years old) with dry skin with one application. Brazil. 2017
(4)Evaluation of Atoderm PP Baume in Atopic Dermatitis – 60 patients (aged < 12 years old) with atopic dermatitis of moderate intensity. Poland. 2009
(5)User test on Atoderm PP Baume – 20 volunteers (aged 20 – 64 years old) with extremely dry skin on their legs under normal conditions. France

> CLINICAL RESULTS

GENERALITIES
Atoderm PP Baume enables a significant increase in the hydration rate of +90.8% * in 2 hours. This action persists after 8 hours (+60.4%) * and 24 hours (+21,3%) * (1)
After 10 days of application of Atoderm PP Baume on the forearms, we observe the development of saprophytic flora to the detriment of Staphylococcus aureus. (2)

ACTION ON ATOPIC DERMATITIS
After 28 days of daily application of Atoderm PP Baume in patients with AD, the results showed a significant decrease in:(3)

• The intensity of scaly skin (-87%)**
• Dry skin sensation  (-72%)**
• Itchiness (-68%)**
• Roughness (-70%)**
• Tight skin sensation (-80%)**
• Body area affected by cutaneous dryness (-75%)**

In a study conducted in children with AD (<12-year-old), the use Atoderm PP Baume decreased significantly by 84%** the cutaneous dryness, 100% the feeling of tightness and by 83%** the feeling of insomnia after 6 months. (4)

Ecodéfensine® patent that combines two active ingredients:
- Boldo extract stimulates the defensins, antibacterial peptides produced in normal skin to defend itself against and inhibits the development of Staphylococcus aureus, one of the principal agents involved in AD (atopic dermatitis) and participating in its maintenance.
- FructoOligoSaccharides (FOS) favour the development and preserve the integrity of the saprophytic flora

The global efficacy of Atoderm PP Baume was excellent to good in 100% of cases, according to the dermatologists and 97.5% of cases, according to the parents. (4)

TOLERANCE
Atoderm Baume presented an excellent level of tolerance. (3)
* p<0.05, Student’s test, after 8 hours            

**p<0.001, Wilcoxon Test, after 28 days or 6 months

> PATIENTS FEEDBACKS
100 % of patients and parents found Atoderm PP Baume easy to spread (3,4)
More than 90% of the patients thought that skin is more supple and hydrated. They feel a prolonged sensation of hydration and generally the skin is more comfortable. (5)

(1)Evaluation of cutaneous hydration rate by corneometric of Atoderm PP Baume, double-blind study – 10 volunteers (aged 28 – 63 years old) with dry or moderately hydrated skin on their forearms with only one application. France
(2)Efficacy of Atoderm PP Baume on skin flora through determination and counts of Staphylococcus aureus strains and coagulase-negative Staphylococcus by swab sampling on the forearms, before and after 10 days of treatment. – 4 volunteers, healthy carriers of Staphylococcus aureus.
(3)Evaluation of Atoderm PP Baume in dry skin during Atopic Dermatitis – 40 patients (1- 14 years old) with dry skin with one application. Brazil. 2017.
(4)Evaluation of Atoderm PP Baume in Atopic Dermatitis – 60 patients (aged < 12 years old) with atopic dermatitis of moderate intensity. Poland. 2009
(5)User test on Atoderm PP Baume – 20 volunteers (aged 20 – 64 years old) with extremely dry skin on their legs under normal conditions. France